91
Views
5
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Bevacizumab for neovascular age-related macular degeneration (ABC trial): multicenter randomized double-masked study

Pages 747-752 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrea Servillo, Ilaria Zucchiatti, Riccardo Sacconi, Mariacristina Parravano, Lea Querques, Paula La Rubia, Francesco Prascina, Francesco Bandello & Giuseppe Querques. (2023) The state-of-the-art pharmacotherapeutic management of neovascular age-related macular degeneration. Expert Opinion on Pharmacotherapy 24:2, pages 197-206.
Read now

Articles from other publishers (4)

Tian Cheng, Taikang Yao, Boxuan Xu, Wanwei Dai, Xuejiao Qin, Juan Ye, Lingge Suo & Chun Zhang. (2023) Using the C-Read as a Portable Device to Evaluate Reading Ability in Young Chinese Adults: An Observational Study. Journal of Personalized Medicine 13:3, pages 463.
Crossref
Jessada Thutkawkorapin, Annika Lindblom & Emma Tham. (2019) Exome sequencing in 51 early onset non‐familial CRC cases . Molecular Genetics & Genomic Medicine 7:5, pages e605.
Crossref
Tomás Rojas, Cristian Cumsille, Rodrigo Castillo, Daniel García, Álvaro Henríquez, Rodrigo Lacroix & Javier Corvalan. (2014) Uso de terapia antifactor de crecimiento vascular endotelial en patología corneal. Revista Mexicana de Oftalmología 88:3, pages 113-119.
Crossref
Yuewen Ma, Lin Qiang & Man He. (2013) Exercise Therapy Augments the Ischemia-Induced Proangiogenic State and Results in Sustained Improvement after Stroke. International Journal of Molecular Sciences 14:4, pages 8570-8584.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.